Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

NCT06814496 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Arizona

Collaborators